drugset
drugset / Trial / NCT07694440

A Study of MZE782 in Adults With PKU

NCT07694440 ↗

Phase 2 Recruiting 38 enrolled Maze Therapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).

Timeline

Start
2026-06-23
Primary completion
2027-12
Completion
2028-02

Drugs

EvaluationDrugModalityDoseRoute
Subject MZE782 Unknown — —

Indications

phenylketonuria